Infectious Disease Connect, a UPMC-backed company specializing in telemedicine services that help hospitals treat infectious diseases, is teaming with Merck-owned Ilum Health Solutions, which offers technology and other services related to managing infectious diseases.
Under the agreement announced Tuesday, UPMC Enterprises — the commercialization arm of Pittsburgh-based UPMC — and Merck Global Health Innovation Fund will invest $5 million in the new entity.
UPMC will retain a majority stake in the combined company, which brings together Infectious Disease Connect’s expertise in treating infectious diseases with the Ilum platform to provide real-time data that will help member hospitals in nine states to use an appropriate therapy while managing costs.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.